aspirin has been researched along with hydrogen sulfide in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (16.67) | 29.6817 |
| 2010's | 22 (73.33) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, E; Cirino, G; Di Sante, M; Distrutti, E; Fiorucci, S; Mencarelli, A; Morelli, A; Orlandi, S; Renga, B; Rizzo, G; Wallace, JL; Zanardo, R | 1 |
| Brancaleone, V; Cirino, G; Distrutti, E; Fiorucci, S; Wallace, JL; Zanardo, RC | 1 |
| Wallace, JL | 1 |
| Góralska, M; Somogyi, E; Srebro, Z; Sura, P; Wiliński, B; Wiliński, J | 1 |
| Del Soldato, P; Erdman, K; Erdmann, K; Giustarini, D; Perrino, E; Rossi, R; Rossoni, G; Schröder, H; Sparatore, A; Tazzari, V | 1 |
| Del Soldato, P; Lee, M; McGeer, E; McGeer, PL; Sparatore, A | 1 |
| Del Soldato, P; Giustarini, D; Rossi, R; Sparatore, A | 1 |
| Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G; Sparatore, A; Tazzari, V; Trivulzio, S | 1 |
| Borretto, E; Chegaev, K; Di Stilo, A; Fruttero, R; Gasco, A; Guglielmo, S; Joseph, S; Lazzarato, L; Marini, E; Rolando, B | 1 |
| Bian, JS; Del Soldato, P; Liu, YY; Sparatore, A | 1 |
| Del Soldato, P; Giustarini, D; Rossi, R; Santus, G; Sparatore, A | 1 |
| Boring, D; Chattopadhyay, M; Kashfi, K; Kodela, R; Nath, N; Street, CR; Velázquez-Martínez, CA | 1 |
| Barsegian, A; Boring, D; Chattopadhyay, M; Kashfi, K; Kodela, R; Nath, N | 1 |
| Boring, D; Chattopadhyay, M; Dastagirzada, YM; Kashfi, K; Kodela, R; Nath, N; Velázquez-Martínez, CA | 1 |
| Del Soldata, P; Ji, D; Majid, AS; Osborne, NN; Sparatore, A | 1 |
| Chattopadhyay, M; Kashfi, K; Kodela, R; Olson, KR | 1 |
| Czermak, T; Del Soldato, P; Fochler, F; Kraemer, BF; Krötz, F; Mannell, H; Pircher, J; Pohl, U; Sparatore, A; Wörnle, M | 1 |
| Bian, JS; Cui, J; Liu, L; Soldato, PD; Song, CJ; Sparatore, A; Wang, XY; Yan, CD | 1 |
| Fan, Y; Gu, T; Guo, C; Sparatore, A; Wang, C; Wu, D; Zhang, A; Zhang, H | 1 |
| Chattopadhyay, M; Gan, ZY; Kashfi, K; Kodela, R; Metkar, S; Nath, N; Sobocki, T | 1 |
| Cheng, C; Gao, L; Sparatore, A; Wang, C; Zhang, H | 1 |
| Cirino, G; Di Minno, A; Di Minno, G; Franchini, M; Lupoli, R; Sorrentino, R; Spadarella, G | 1 |
| Chattopadhyay, M; Kashfi, K; Kodela, R; Rao, PPN; Vannini, F | 1 |
| Chattopadhyay, M; Eschbach, EK; Kashfi, K; Kodela, R; MacKessack-Leitch, AC; Vannini, F | 1 |
| Chattopadhyay, M; Kashfi, K; Kodela, R; Velázquez-Martínez, CA | 1 |
| Chen, L; Kang, JM; Lai, ZZ; Li, X; Meng, FH; Shi, K; Wang, RY; Xian, M; Yang, CT; Zhang, H; Zheng, ZH | 1 |
| Jiao, F; Lin, J; Ma, L; Zhao, H | 1 |
| Jiao, F; Lin, J; Ma, L; Wang, W; Zhao, H | 1 |
| Antoniou, C; Chatzimichail, G; Christou, A; Fotopoulos, V; Kashfi, K; Xenofontos, R | 1 |
| Agrawal, S; Ahmad, S; Ahmed, A; Alzahrani, FA; Dias, IH; Rezai, H; Sanchez-Aranguren, L; Sparatore, A; Wang, K | 1 |
3 review(s) available for aspirin and hydrogen sulfide
| Article | Year |
|---|---|
Building a better aspirin: gaseous solutions to a century-old problem.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemistry, Pharmaceutical; Gastrointestinal Hemorrhage; Humans; Hydrogen Sulfide; Models, Biological; Molecular Structure; Stomach Ulcer | 2007 |
Therapeutic potential of new hydrogen sulfide-releasing hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Humans; Hydrogen Sulfide; Inflammation; Latanoprost; Levodopa; Prodrugs; Prostaglandins F, Synthetic | 2011 |
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide.
Topics: Animals; Aspirin; Atherosclerosis; Folic Acid; Gasotransmitters; Homocysteine; Humans; Hydrogen Sulfide; Methionine; Methylation; Oxidation-Reduction; Thrombosis | 2015 |
27 other study(ies) available for aspirin and hydrogen sulfide
| Article | Year |
|---|---|
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Cloning, Molecular; Cystathionine gamma-Lyase; Disease Models, Animal; Gastric Mucosa; Gene Expression Regulation, Enzymologic; Genes, Reporter; Humans; Hydrogen Sulfide; Luciferases; Male; Promoter Regions, Genetic; Rats; Rats, Wistar; Stomach Diseases | 2005 |
Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation.
Topics: Animals; Aspirin; Cell Adhesion; Cell Movement; Endothelium, Vascular; Hydrogen Sulfide; Inflammation; Inflammation Mediators; Leukocytes; Microscopy, Video; Rats; Splanchnic Circulation; Sulfides; Venules | 2006 |
Aspirin augments the concentration of endogenous hydrogen sulfide in mouse brain and liver.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Brain Chemistry; Female; Humans; Hydrogen Sulfide; Liver; Lysine; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; S-Adenosylmethionine; Sex Factors | 2006 |
Pharmacological profile of a novel H(2)S-releasing aspirin.
Topics: 3T3 Cells; Animals; Aorta, Thoracic; Aspirin; Chromatography, High Pressure Liquid; Disulfides; Gastric Mucosa; Glutathione; Heme Oxygenase-1; Hydrogen Sulfide; Isoprostanes; Male; Mice; Myocardium; Promoter Regions, Genetic; Rats; Rats, Wistar; Thromboxanes; Transcriptional Activation; Transfection | 2009 |
Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation.
Topics: Air Pollutants; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Astrocytes; Cell Survival; Cells, Cultured; Humans; Hydrogen Sulfide; Interleukin-6; Intracellular Fluid; Lipopolysaccharides; Microglia; Neuroprotective Agents; Nitrites; Temporal Lobe; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Modulation of thiol homeostasis induced by H2S-releasing aspirin.
Topics: Anethole Trithione; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromatography, High Pressure Liquid; Glutathione; Homeostasis; Hydrogen Sulfide; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 2010 |
Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats.
Topics: Animals; Aorta; Aspirin; Blood Pressure; Consciousness; Creatine Kinase; Endothelium, Vascular; Gastric Mucosa; Glutathione; Heart; Heart Rate; Hydrogen Sulfide; L-Lactate Dehydrogenase; Male; Malondialdehyde; Metabolic Syndrome; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Vasodilation | 2010 |
New nitric oxide or hydrogen sulfide releasing aspirins.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Aspirin; Humans; Hydrogen Sulfide; Male; Muscle Relaxation; Nitric Oxide; Nitric Oxide Donors; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Vasodilator Agents | 2011 |
H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells.
Topics: Amyloid beta-Peptides; Animals; Aspirin; Cell Line, Transformed; Cell Survival; Cyclooxygenase 2; Dose-Response Relationship, Drug; Hydrogen Sulfide; Lactate Dehydrogenases; Membrane Potential, Mitochondrial; Mice; Microglia; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protective Agents; Tetrazolium Salts; Thiazoles; Transcription Factor CHOP; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |
Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Topics: Animals; Aspirin; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP1A1; Gene Expression Regulation; Glucuronosyltransferase; Glutathione Transferase; HT29 Cells; Humans; Hydrogen Sulfide; Inhibitory Concentration 50; Liver; Male; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Mice; NAD(P)H Dehydrogenase (Quinone); Neoplasms; NF-E2-Related Factor 2; Rats; Rats, Wistar; Sodium Fluoride; Thiones | 2012 |
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Hydrogen Sulfide; Mice; NF-kappa B; Reactive Oxygen Species; Receptors, Estrogen; Signal Transduction; Thiones; Thioredoxin-Disulfide Reductase; Xenograft Model Antitumor Assays | 2012 |
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Growth Inhibitors; Humans; Hydrogen Sulfide; Ibuprofen; Naproxen; Sulindac; Thiones | 2012 |
Glutamate oxidative injury to RGC-5 cells in culture is necrostatin sensitive and blunted by a hydrogen sulfide (H2S)-releasing derivative of aspirin (ACS14).
Topics: Aspirin; Base Sequence; Cell Line, Transformed; DNA Primers; Glutamic Acid; Glutathione; Hydrogen Sulfide; Imidazoles; Immunohistochemistry; Indoles; Oxidative Stress; Polymerase Chain Reaction; Reactive Oxygen Species | 2012 |
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase Inhibitors; Disulfides; HT29 Cells; Humans; Hydrogen Sulfide; Mice; Mice, Nude; Nitrates; Nitric Oxide; Nitric Oxide Donors; Prostaglandin-Endoperoxide Synthases; Rats; Xenograft Model Antitumor Assays | 2012 |
Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.
Topics: Animals; Aspirin; Bleeding Time; Blood Platelets; Cyclic AMP; Disulfides; Fibrinolytic Agents; Humans; Hydrogen Sulfide; In Vitro Techniques; Integrins; Mice; Mice, Inbred C57BL; Models, Animal; Platelet Activation; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Thrombosis | 2012 |
H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress.
Topics: Animals; Aspirin; Cyclooxygenase 2; Delayed-Action Preparations; Dinoprostone; Disulfides; Dose-Response Relationship, Drug; Gastric Mucosa; Gene Expression Regulation; Glutathione; Hydrogen Sulfide; Male; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase; Superoxide Dismutase-1; Xanthine Oxidase | 2012 |
Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Topics: Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Brachiocephalic Trunk; Cell Line; Chemotaxis; CX3C Chemokine Receptor 1; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Down-Regulation; Gastric Mucosa; Hydrogen Sulfide; Immunohistochemistry; Injections, Intraperitoneal; Interferon-gamma; Intestinal Mucosa; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; PPAR gamma; Receptors, Chemokine; Time Factors | 2012 |
Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.
Topics: Aspirin; beta Catenin; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Expression Regulation; Humans; Hydrogen Sulfide; Jurkat Cells | 2013 |
Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin.
Topics: Adult; Aspirin; Blood Platelets; Disulfides; Dose-Response Relationship, Drug; Female; Gap Junctions; Gasotransmitters; Humans; Hydrogen Sulfide; Male; Platelet Aggregation; Platelet Aggregation Inhibitors | 2015 |
Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disulfides; Gene Expression; HT29 Cells; Humans; Hydrogen Sulfide; Inhibitory Concentration 50; Molecular Docking Simulation; Nitrates; Nitric Oxide; Nitric Oxide Donors; Sheep; Stereoisomerism; Structure-Activity Relationship | 2015 |
Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.
Topics: Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disulfides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Hydrogen Sulfide; Molecular Structure; Nitrates; Nitric Oxide; Reactive Oxygen Species; Structure-Activity Relationship | 2015 |
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemoprevention; Disulfides; Dose-Response Relationship, Drug; Gastric Mucosa; Gastrointestinal Tract; HT29 Cells; Humans; Hydrogen Sulfide; Male; Mice; Mice, Nude; Nitrates; Nitric Oxide; Rats; Rats, Wistar; Xenograft Model Antitumor Assays | 2015 |
A novel pH-controlled hydrogen sulfide donor protects gastric mucosa from aspirin-induced injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Cyclooxygenase 2; Cystathionine gamma-Lyase; Epithelial Cells; Gastric Mucosa; Humans; Hydrogen Sulfide; Hydrogen-Ion Concentration; Interleukin-6; Male; Mice; Molecular Structure; Organothiophosphonates; Protective Agents; Tumor Necrosis Factor-alpha | 2017 |
Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study.
Topics: Administration, Oral; Adolescent; Aspirin; Biomarkers; Case-Control Studies; Child; Drug Resistance; Drug Therapy, Combination; Echocardiography; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrogen Sulfide; Immunoglobulins, Intravenous; Lymphocytes; Male; Mucocutaneous Lymph Node Syndrome; Reproducibility of Results; Young Adult | 2018 |
Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
Topics: Aspirin; Biomarkers; Case-Control Studies; Child; Child, Preschool; Coronary Artery Disease; Coronary Vessels; Echocardiography, Doppler, Color; Enzyme-Linked Immunosorbent Assay; Female; Fever; Humans; Hydrogen Sulfide; Immunoglobulins, Intravenous; Infant; Lymphocytes; Male; Mucocutaneous Lymph Node Syndrome; Predictive Value of Tests; ROC Curve | 2020 |
Exploring the Potential of Nitric Oxide and Hydrogen Sulfide (NOSH)-Releasing Synthetic Compounds as Novel Priming Agents against Drought Stress in
Topics: Acclimatization; Agrochemicals; Aspirin; Disulfides; Droughts; Hydrogen Sulfide; Medicago sativa; Nitrates; Nitric Oxide; Stress, Physiological | 2020 |
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.
Topics: Animals; Aspirin; Female; Heme Oxygenase-1; Hydrogen Sulfide; Membrane Proteins; Mice; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factor Receptor-1 | 2021 |